These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8475320)

  • 1. Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects.
    el-Mallakh RS; Suddath RL; Wyatt RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):383-91. PubMed ID: 8475320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.
    Barak V; Barak Y; Levine J; Nisman B; Roisman I
    J Basic Clin Physiol Pharmacol; 1995; 6(1):61-9. PubMed ID: 8562579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers.
    Rapaport MH; McAllister CG; Pickar D; Tamarkin L; Kirch DG; Paul SM
    Schizophr Res; 1997 May; 25(2):123-9. PubMed ID: 9187011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.
    Licinio J; Seibyl JP; Altemus M; Charney DS; Krystal JH
    Am J Psychiatry; 1993 Sep; 150(9):1408-10. PubMed ID: 8102512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.
    Katila H; Hurme M; Wahlbeck K; Appelberg B; Rimón R
    Neuropsychobiology; 1994; 30(1):20-3. PubMed ID: 7969854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status.
    McAllister CG; van Kammen DP; Rehn TJ; Miller AL; Gurklis J; Kelley ME; Yao J; Peters JL
    Am J Psychiatry; 1995 Sep; 152(9):1291-7. PubMed ID: 7653683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
    Blum-Degen D; Müller T; Kuhn W; Gerlach M; Przuntek H; Riederer P
    Neurosci Lett; 1995 Dec; 202(1-2):17-20. PubMed ID: 8787820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype.
    Garver DL; Tamas RL; Holcomb JA
    Neuropsychopharmacology; 2003 Aug; 28(8):1515-20. PubMed ID: 12799618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein).
    List J; Moser RP; Steuer M; Loudon WG; Blacklock JB; Grimm EA
    Cancer Res; 1992 Mar; 52(5):1123-8. PubMed ID: 1737371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of interleukin-2 in cerebrospinal fluid by a sensitive enzyme-linked immunosorbent assay.
    Sharief MK; Hentges R; Thompson EJ
    J Immunol Methods; 1992 Feb; 147(1):51-6. PubMed ID: 1541841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased interleukin-2 production in Korean schizophrenic patients.
    Kim YK; Lee MS; Suh KY
    Biol Psychiatry; 1998 May; 43(9):701-4. PubMed ID: 9583005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia.
    Prasad C; Hilton CW; Lohr JB; Robertson HJ
    Neuropeptides; 1991 Nov; 20(3):187-90. PubMed ID: 1762668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors beta 1 and beta 2 in the cerebrospinal fluid of chronic schizophrenic patients.
    Vawter MP; Dillon-Carter O; Issa F; Wyatt RJ; Freed WJ
    Neuropsychopharmacology; 1997 Jan; 16(1):83-7. PubMed ID: 8981392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture.
    Nishino S; Mignot E; Benson KL; Zarcone VP
    Psychiatry Res; 1998 May; 78(3):141-50. PubMed ID: 9657418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Engelborghs S; De Brabander M; De Crée J; D'Hooge R; Geerts H; Verhaegen H; De Deyn PP
    Neurochem Int; 1999 Jun; 34(6):523-30. PubMed ID: 10402228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB; Boctor FN; Tourtellotte WW
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus and schizophrenia. A test of a viral hypothesis.
    Shrikhande S; Hirsch SR; Coleman JC; Reveley MA; Dayton R
    Br J Psychiatry; 1985 May; 146():503-6. PubMed ID: 2990626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.